首页> 美国卫生研究院文献>other >Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese Populations
【2h】

Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese Populations

机译:CD44基因中的微小RNA结合位点的功能遗传变异与中国人群大肠癌的风险。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

CD44 as one of the most putative stem cell markers plays a key role in many cellular processes, including cancer cell growth and migration. Functional single nucleotide polymorphisms (SNPs) of CD44 may modulate its gene functions and thus cancer risk. In the current study, we investigated if polymorphisms in the 3’-untranslated region (UTR) of CD44 are associated with increased susceptibility to colorectal cancer (CRC) by conducting a case-control study of 946 CRC patients and 989 cancer-free controls. Three polymorphisms (rs13347C/T, rs10836347C/T, rs11821102G/A) in the 3’-UTR of CD44 were genotyped. We found that the variant genotypes (CT and TT) of rs13347 (adjusted odds ratio (OR)=1.79, 95% confidence interval (CI)=1.50-2.17) increased an individual’s susceptibility to CRC, compared with rs13347CC homozygous genotypes. We also found that CRC patients with the CT/TT genotype had a 1.6-fold increased risk for developing advanced (stage III + IV) CRC. Furthermore, functional assays showed that the C to T base change at rs13347C/T disrupts the binding site for the microRNA hsa-mir-509-3p, thereby increasing CD44 transcriptional activity and expression level. These findings suggest that the rs13347C/T in microRNA binding site may be potential biomarkers for genetic susceptibility to CRC.
机译:CD44作为最可能的干细胞标记之一,在许多细胞过程(包括癌细胞的生长和迁移)中起着关键作用。 CD44的功能性单核苷酸多态性(SNP)可能会调节其基因功能,从而调节癌症风险。在当前的研究中,我们通过对946名CRC患者和989名无癌对照进行病例对照研究,调查了CD44 3'非翻译区(UTR)的多态性是否与大肠癌(CRC)的易感性有关。对CD44 3'-UTR中的三个多态性(rs13347C / T,rs10836347C / T,rs11821102G / A)进行了基因分型。我们发现,与rs13347CC纯合基因型相比,rs13347的变异基因型(CT和TT)(调整比值比(OR)= 1.79,95%置信区间(CI)= 1.50-2.17)增加了个体对CRC的敏感性。我们还发现,具有CT / TT基因型的CRC患者发生晚期(III + IV期)CRC的风险增加了1.6倍。此外,功能分析表明,rs13347C / T处C到T碱基的变化破坏了microRNA hsa-mir-509-3p的结合位点,从而增加了CD44转录活性和表达水平。这些发现表明,微小RNA结合位点中的rs13347C / T可能是CRC对遗传易感性的潜在生物标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号